Imaflex Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Imaflex yıllık ortalama 5% oranında kazançlarını artırırken, Packaging sektöründe kazançlar growing at 5% annual. Gelirler growing yılda ortalama 4.7% oranında artmaktadır. Imaflex'in özkaynak karlılığı 7.2% ve net marjı 4.3%'dir.

Anahtar bilgiler

5.0%

Kazanç büyüme oranı

4.3%

EPS büyüme oranı

Packaging Sektör Büyümesi	6.1%
Gelir büyüme oranı	4.7%
Özkaynak getirisi	7.2%
Net Marj	4.3%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

There May Be Some Bright Spots In Imaflex's (CVE:IFX) Earnings

Jun 05

Recent updates

Imaflex (CVE:IFX) Is Reinvesting At Lower Rates Of Return

Aug 29

Market Might Still Lack Some Conviction On Imaflex Inc. (CVE:IFX) Even After 28% Share Price Boost

Aug 29

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imaflex Inc.'s (CVE:IFX) CEO For Now

Jun 10

Imaflex (CVE:IFX) Seems To Use Debt Rather Sparingly

Jun 03

Here's Why I Think Imaflex (CVE:IFX) Might Deserve Your Attention Today

Apr 19

Imaflex (CVE:IFX) Shareholders Will Want The ROCE Trajectory To Continue

Mar 30

Did Imaflex Inc. (CVE:IFX) Insiders Sell Shares?

Mar 01

Is Imaflex Inc.'s (CVE:IFX) Latest Stock Performance A Reflection Of Its Financial Health?

Feb 04

Is Imaflex (CVE:IFX) A Risky Investment?

Jan 17

What We Make Of Imaflex's (CVE:IFX) Returns On Capital

Dec 30

Imaflex (CVE:IFX) Is Growing Earnings But Are They A Good Guide?

Dec 15

Have Insiders Sold Imaflex Inc. (CVE:IFX) Shares Recently?

Nov 30

What Does Imaflex's (CVE:IFX) CEO Pay Reveal?

Nov 26

Gelir ve Gider Dağılımı

Imaflex nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

TSXV:IFX Gelir, gider ve kazançlar (CAD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	102	4	8
31 Mar 24	98	1	8
31 Dec 23	94	1	8
30 Sep 23	92	2	9
30 Jun 23	96	5	8
31 Mar 23	104	8	8
31 Dec 22	112	9	8
30 Sep 22	115	10	8
30 Jun 22	118	10	8
31 Mar 22	114	8	7
31 Dec 21	107	8	7
30 Sep 21	104	8	7
30 Jun 21	97	7	7
31 Mar 21	91	5	7
31 Dec 20	87	6	7
30 Sep 20	83	5	7
30 Jun 20	80	4	7
31 Mar 20	80	4	7
31 Dec 19	81	2	7
30 Sep 19	85	2	7
30 Jun 19	87	2	7
31 Mar 19	88	2	6
31 Dec 18	86	4	6
30 Sep 18	85	4	7
30 Jun 18	85	4	7
31 Mar 18	87	4	7
31 Dec 17	88	4	7
30 Sep 17	86	3	7
30 Jun 17	82	3	7
31 Mar 17	76	2	7
31 Dec 16	74	0	6
30 Sep 16	72	1	6
30 Jun 16	72	1	6
31 Mar 16	73	1	6
31 Dec 15	69	1	6
30 Sep 15	68	1	6
30 Jun 15	66	0	6
31 Mar 15	62	0	5
31 Dec 14	61	0	5
30 Sep 14	59	0	5
30 Jun 14	59	-1	5
31 Mar 14	58	0	5
31 Dec 13	56	0	5

Kaliteli Kazançlar: IFX yüksek kaliteli kazançlar sağlıyor.

Büyüyen Kar Marjı: IFX 'nin mevcut net kar marjları (4.3%) geçen yılın (5.2%) değerinden daha düşüktür.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: IFX şirketinin kazancı son 5 yılda yılda 5% oranında arttı.

Büyüme Hızlandırma: IFX 'in son bir yıldır negatif kazanç büyümesi oldu, bu nedenle 5 yıllık ortalamasıyla karşılaştırılamaz.

Kazançlar vs. Sektör: IFX geçtiğimiz yıl negatif kazanç büyümesine ( -11.1% ) sahipti ve bu da onu Packaging sektör ortalamasıyla ( 2.3% ) karşılaştırmayı zorlaştırıyordu.

Özkaynak Getirisi

Yüksek ROE: IFX 'nin Özsermaye Getirisi ( 7.2% ) düşük olarak değerlendiriliyor.

Imaflex Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 2/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Second quarter 2024 earnings released: EPS: CA$0.07 (vs CA$0.008 in 2Q 2023)

There May Be Some Bright Spots In Imaflex's (CVE:IFX) Earnings

First quarter 2024 earnings released: EPS: CA$0.04 (vs CA$0.018 in 1Q 2023)

Full year 2023 earnings released: EPS: CA$0.01 (vs CA$0.18 in FY 2022)

Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.06 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CA$0.01 (vs CA$0.066 in 2Q 2022)

Recent updates

Insider recently sold CA$59k worth of stock

Imaflex Inc. Announces CEO Changes, Effective October 28, 2024

Second quarter 2024 earnings released: EPS: CA$0.07 (vs CA$0.008 in 2Q 2023)

Imaflex (CVE:IFX) Is Reinvesting At Lower Rates Of Return

Market Might Still Lack Some Conviction On Imaflex Inc. (CVE:IFX) Even After 28% Share Price Boost

Investor sentiment improves as stock rises 24%

Revenues Not Telling The Story For Imaflex Inc. (CVE:IFX) After Shares Rise 48%

Investor sentiment improves as stock rises 18%

There May Be Some Bright Spots In Imaflex's (CVE:IFX) Earnings

First quarter 2024 earnings released: EPS: CA$0.04 (vs CA$0.018 in 1Q 2023)

Insufficient new directors

Full year 2023 earnings released: EPS: CA$0.01 (vs CA$0.18 in FY 2022)

Imaflex Inc., Annual General Meeting, Jun 13, 2024

Imaflex (CVE:IFX) Might Be Having Difficulty Using Its Capital Effectively

Third quarter 2023 earnings released: EPS: CA$0.003 (vs CA$0.06 in 3Q 2022)

Is Imaflex (CVE:IFX) A Risky Investment?

Second quarter 2023 earnings released: EPS: CA$0.01 (vs CA$0.066 in 2Q 2022)

Investor sentiment deteriorates as stock falls 18%

Insider recently sold CA$67k worth of stock

Imaflex Inc. Announces CEO Changes

Imaflex Inc. Appoints Roger Tambay as CEO

First quarter 2023 earnings released: EPS: CA$0.02 (vs CA$0.04 in 1Q 2022)

Imaflex Inc. Announces Chief Financial Officer Changes

Does Imaflex (CVE:IFX) Deserve A Spot On Your Watchlist?

Full year 2022 earnings released: EPS: CA$0.18 (vs CA$0.17 in FY 2021)

We Think Imaflex (CVE:IFX) Can Stay On Top Of Its Debt

Third quarter 2022 earnings released: EPS: CA$0.06 (vs CA$0.055 in 3Q 2021)

Imaflex Inc. Provides Earnings Guidance for the Full Year 2022

Price target increased to CA$1.95

Insufficient new directors

Imaflex Inc. Submits Advaseal® Registration Package to the EPA

Does Imaflex (CVE:IFX) Have A Healthy Balance Sheet?

Second quarter 2022 earnings released: EPS: CA$0.07 (vs CA$0.04 in 2Q 2021)

VP of Manufacturing recently sold CA$56k worth of stock

First quarter 2022 earnings released: EPS: CA$0.04 (vs CA$0.039 in 1Q 2021)

Is It Too Late To Consider Buying Imaflex Inc. (CVE:IFX)?

Price target increased to CA$1.95

Insufficient new directors

Imaflex Inc. Provides Earnings Guidance for the First Quarter 2022

Full year 2021 earnings released: EPS: CA$0.17 (vs CA$0.13 in FY 2020)

Imaflex Inc., Annual General Meeting, Jun 16, 2022

Imaflex Inc. Appoints Roberto Longo as Director, Chair the Audit Committee

Imaflex Inc. Announces Resignation of Mario Settino as Director

Vice-President of Corporate Affairs recently sold CA$56k worth of stock

Third quarter 2021 earnings: EPS in line with analyst expectations despite revenue beat

Imaflex (CVE:IFX) Could Easily Take On More Debt

Insider recently sold CA$520k worth of stock

VP of Manufacturing recently sold CA$98k worth of stock

Insider exercised options to buy CA$540k worth of stock.

Investors Should Be Encouraged By Imaflex's (CVE:IFX) Returns On Capital

Vice-President of Corporate Affairs exercised options to buy CA$735k worth of stock.

Second quarter 2021 earnings released: EPS CA$0.04 (vs CA$0.007 in 2Q 2020)

We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Imaflex Inc.'s (CVE:IFX) CEO For Now

Imaflex (CVE:IFX) Seems To Use Debt Rather Sparingly

First quarter 2021 earnings released: EPS CA$0.039 (vs CA$0.062 in 1Q 2020)

Here's Why I Think Imaflex (CVE:IFX) Might Deserve Your Attention Today

Full year 2020 earnings released: EPS CA$0.13 (vs CA$0.031 in FY 2019)

Investor sentiment improved over the past week

Imaflex (CVE:IFX) Shareholders Will Want The ROCE Trajectory To Continue

Did Imaflex Inc. (CVE:IFX) Insiders Sell Shares?

Is Imaflex Inc.'s (CVE:IFX) Latest Stock Performance A Reflection Of Its Financial Health?

Imaflex Announces Positive Independent Results for the ADVASEAL Release Study

New 90-day high: CA$1.22

Is Imaflex (CVE:IFX) A Risky Investment?

What We Make Of Imaflex's (CVE:IFX) Returns On Capital

Imaflex (CVE:IFX) Is Growing Earnings But Are They A Good Guide?

Have Insiders Sold Imaflex Inc. (CVE:IFX) Shares Recently?

Insider recently sold CA$108k worth of stock

Revenue beats expectations